Cassie Clinton

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham

Presentation(s):

• SP03K - Disease Severity and Outcomes Among Patients with Rheumatoid Arthritis Who Receive a Newly Approved Biologic: Real-world US Experience with Sarilumab from the ACR RISE Registry

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• OP-12A - Participant Engagement and Adherence in an Arthritispower Real-world Study to Capture Smartwatch and Patient-reported Outcome Data Among Rheumatoid Arthritis Patients

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time